Axcelis CEO sells 1,244 shares under trading plan
Axcelis Technologies Inc. president and CEO Russell Low reported an open-market sale of 1,244 shares of common stock at $138.86 per share on May 1, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Axcelis Technologies Inc. president and CEO Russell Low reported an open-market sale of 1,244 shares of common stock at $138.86 per share on May 1, 2026. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 11, 2025.
After this sale, Low directly held 131,038 shares of Axcelis common stock. Of this amount, 83,480 shares were issuable upon vesting of restricted stock units granted under the company’s 2012 Equity Incentive Plan and remain subject to forfeiture.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,244 | $138.86 | $173K |
Footnotes (2)
- F1. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2025.
- F2. Of the shares held after this sale on May 1, 2026, 83,480 were issuable on vesting of restricted stock units granted to the reporting person under the 2012 Equity Incentive Plan and are subject to forfeiture.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
restricted stock units financial
2012 Equity Incentive Plan financial
open-market sale financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Axcelis Technologies (ACLS) report for Russell Low?
How many restricted stock units does the Axcelis (ACLS) CEO have after the sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.